Wednesday, July 8, 2015

Mass General study suggests that medication could improve gastric bypass results

In a study led by Lee Kaplan, MD, PhD, director of theObesity, Metabolism and Nutrition Institute at Massachusetts General Hospital, researchers found that weight-loss activating pathways could be targeted with complementary therapies in order to improve Roux-en-Y gastric bypass (RYGB) surgical outcomes.Learn more

Back to Top